NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

That (pathway B) is still a plan whereby the MHRA will approve faster for drugs already approved ex-UK.

In one post you assert nobody is pushing that nonsense of it applying to -L, and in the next you yourself push it.

There is no leeway in plan B for the "approved by others" point.

To be eligible for Recognition B, the RR approval should have been granted within the previous 10 years. A CHMP positive opinion or an MRDC positive end of procedure outcome is an RR approval for the purposes of IRP.